Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Neoplasms of the CNS

  Free Subscription


19.10.2026

3 Acta Neuropathol
2 BMC Cancer
1 Cancer Res
2 Childs Nerv Syst
1 Eur J Cancer
1 Int J Cancer
3 Int J Radiat Oncol Biol Phys
1 J Clin Oncol
11 J Neurooncol
2 J Nucl Med
1 Nat Rev Neurol
10 Neuro Oncol
1 Neurol Clin Pract
1 Neuroradiology
1 Neurosurgery
1 Pediatr Neurol
1 PLoS One


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Acta Neuropathol

  1. DONSON AM, Griesinger AM, Chapman RJ, Grundy RG, et al
    Chromosome 6q mediated loss of LATS1 tumour suppression as a targetable mechanism of ultra-high-risk posterior fossa A ependymoma.
    Acta Neuropathol. 2026;152:52.
    PubMed         Abstract available

  2. SHEN F, Sheng H
    MGMT expression in pediatric H3 G34-mutant diffuse hemispheric glioma: technical covariates should be addressed before clinical use.
    Acta Neuropathol. 2026;152:55.
    PubMed        

  3. ZHANG Q, Tlais D, Lin T, Li X, et al
    The association between MGMT expression and outcome in H3 G34-mutant diffuse hemispheric glioma is robust to adjustment for pre-analytic and technical variables.
    Acta Neuropathol. 2026;152:56.
    PubMed        


    BMC Cancer

  4. TAN MW, Ling V, Tan JY, Chan WL, et al
    Autologous stem cell transplantation for secondary central nervous system lymphoma: a multicentre retrospective analysis.
    BMC Cancer. 2026 Jul 14. doi: 10.1186/s12885-026-16531.
    PubMed         Abstract available

  5. KHADHRAOUI E, Schmidt L, Klebingat S, Sandalcioglu IE, et al
    Late enhancement and washout maps for distinguishing tumor progression from radiation necrosis in malignant brain tumors: an exploratory study.
    BMC Cancer. 2026;26:1238.
    PubMed         Abstract available


    Cancer Res

  6. GRAUSAM KB, Pioso MS, Sanchez JC, Li M, et al
    A syngeneic murine glioma model recapitulates key molecular, immunologic, and functional features of human glioblastoma to enable therapeutic development.
    Cancer Res. 2026 Oct 13. doi: 10.1158/0008-5472.CAN-25-5766.
    PubMed         Abstract available


    Childs Nerv Syst

  7. ERTEKIN M, Temuroglu A, Aksoy GR, Taskapilioglu MO, et al
    Long-term outcomes of pediatric medulloblastoma before routine molecular classification: a 20-year single-center cohort study.
    Childs Nerv Syst. 2026;42:391.
    PubMed         Abstract available

  8. SORDYL R, Wyroba N, Karliczek J, Pniok W, et al
    The role of tumor biopsy in children with obstructive hydrocephalus treated with endoscopic third ventriculostomy: a single-center experience.
    Childs Nerv Syst. 2026;42:390.
    PubMed         Abstract available


    Eur J Cancer

  9. KHOURI C, Bibollet A, Bouchoucha Y, Combarel D, et al
    Real-life efficacy and tolerance of trametinib in BRAF-rearranged low-grade gliomas: A multicenter study.
    Eur J Cancer. 2026;248:117450.
    PubMed         Abstract available


    Int J Cancer


  10. Correction to "RIST: A Potent New Combination Therapy for Glioblastoma".
    Int J Cancer. 2026 Oct 14. doi: 10.1002/ijc.70777.
    PubMed        


    Int J Radiat Oncol Biol Phys

  11. JAFARI M, Hosseini S, Taleei R, Saraei P, et al
    Radiation-Induced Alopecia in Patients Undergoing Intracranial Radiation Therapy: A Systematic Review.
    Int J Radiat Oncol Biol Phys. 2026;126:1097-1110.
    PubMed         Abstract available

  12. KIM N, Seo SH, Chang JS, Moon SG, et al
    Deep Learning Blood Dosimetry Predicts Severe Lymphopenia and Survival After Craniospinal Irradiation.
    Int J Radiat Oncol Biol Phys. 2026;126:1040-1051.
    PubMed         Abstract available

  13. TANG H, Xu J, Xiao Z, Wu Y, et al
    Total-Body PET/CT Imaging After Proton Craniospinal Irradiation in Pediatric Patients: A Brief Report.
    Int J Radiat Oncol Biol Phys. 2026;126:1034-1039.
    PubMed         Abstract available


    J Clin Oncol

  14. PADEVIT L, Weiss T, Vasella F, Neidert MC, et al
    Neurodevelopmental Blueprint in Gliomas: Toward an Ontogenetic Multimodal Integrated Therapy.
    J Clin Oncol. 2026 Oct 14:JCO2502798. doi: 10.1200/JCO-25-02798.
    PubMed         Abstract available


    J Neurooncol

  15. CHUANG FT, Chen KT, Wei KC, Chen YC, et al
    Tumor-related epilepsy and preoperative cognitive performance in glioma: a preliminary study.
    J Neurooncol. 2026;180:11.
    PubMed         Abstract available

  16. SCHULTZ SE, Labib M, Breit J, Barreto JN, et al
    Comparative dosing of bevacizumab for radiation necrosis: impact of tumor type on edema response.
    J Neurooncol. 2026;180:12.
    PubMed         Abstract available

  17. HEY G, Del Sesto M, Still M, Patel G, et al
    Leveraging traditional and advanced machine learning for comprehensive oncology data integration and outcome prediction.
    J Neurooncol. 2026;180:13.
    PubMed         Abstract available

  18. DO TJ, Shafqat S, Kizilbash SH, Ida CM, et al
    MGMT promoter methylation as a molecular biomarker in neuro-oncology: current practices, challenges, and future directions.
    J Neurooncol. 2026;180:16.
    PubMed         Abstract available

  19. DONNINI F, Pastina P, Battaglia G, Chibbaro S, et al
    Monocytic resilience during chemoradiotherapy is independently associated with survival in IDH-Wildtype glioblastoma.
    J Neurooncol. 2026;180:15.
    PubMed         Abstract available

  20. HAISRAELY O, Panthi B, Noll KR, Konstantinopoulou E, et al
    Weekly hippocampal diffusion changes during partial-brain radiation therapy for high-grade glioma: associations with dose and early memory change.
    J Neurooncol. 2026;180:14.
    PubMed         Abstract available

  21. CHENG J, Chen Z, Li D, Guo Z, et al
    Radiological features of peritumoral brain injury and neurological outcomes after glioma surgery: a prospective observational study.
    J Neurooncol. 2026;180:17.
    PubMed         Abstract available

  22. HURYOL C, Sulaimanov U, Yuce M, Sanlier N, et al
    MRI-based preoperative WHO grade prediction in meningioma: development and comparison of deep learning, radiomics, clinical, and combined models in multicenter data.
    J Neurooncol. 2026;180:18.
    PubMed         Abstract available

  23. SINGNURKAR A, Sahgal A, Lechtman E, Lim-Fat MJ, et al
    Volumetric discordance between (1)(8)F-FET-PET/MRI and MRI-based radiotherapy target volumes in high-grade glioma: a prospective pilot study (FETSMaRT).
    J Neurooncol. 2026;180:20.
    PubMed         Abstract available

  24. YANG Y, Leenstra JL, Brown PD, Wadhwani N, et al
    Long term outcomes and predictors of recurrence in central neurocytomas: a 35-year multi-institutional experience.
    J Neurooncol. 2026;180:19.
    PubMed         Abstract available

  25. ZHANG M, Xie L, Zhou H, Jiang K, et al
    Longitudinal motor recovery trajectories in brainstem glioma associated with preoperative DTI-based corticospinal tract involvement patterns.
    J Neurooncol. 2026;180:21.
    PubMed         Abstract available


    J Nucl Med

  26. MARULANDA-CORZO V, Farid M, Hill T, Haghdel A, et al
    Brain-Specific Quantification of Somatostatin Receptor Expression: SUV(max) and SUVR(sss) as Quantitative Correlates of the Krenning Score in Meningioma.
    J Nucl Med. 2026 Oct 15:jnumed.126.272351. doi: 10.2967/jnumed.126.272351.
    PubMed         Abstract available

  27. GARABEDIAN N, Zaragori T, Tabouret E, Taillandier L, et al
    Radiopharmaceutical Therapy with [(177)Lu]Lu-DOTATATE in Refractory Meningiomas: Results from the French Multicenter MELUTE Cohort.
    J Nucl Med. 2026 Oct 15:jnumed.126.272735. doi: 10.2967/jnumed.126.272735.
    PubMed         Abstract available


    Nat Rev Neurol

  28. FYFE I
    Astrocytes support glioblastoma cells via tunnelling nanotubes.
    Nat Rev Neurol. 2026 Oct 9. doi: 10.1038/s41582-026-01281.
    PubMed        


    Neuro Oncol

  29. YANG WC, Chen YF, Yang CC, Lu SH, et al
    Unilateral vs Bilateral Hippocampal Avoidance During WBRT With Memantine for Brain Metastases: A Randomized Single-Blind Phase 2 Clinical Trial.
    Neuro Oncol. 2026 Oct 16:noag261. doi: 10.1093.
    PubMed         Abstract available

  30. DIAZ-FERNANDEZ B, Henao-Herreno D, Dossi E, Le Marchand A, et al
    Routing to the seizure in postoperative human glioma cortex: spatio-temporal uncoupling between slow and fast extracellular neuronal activities.
    Neuro Oncol. 2026 Oct 16:noag258. doi: 10.1093.
    PubMed         Abstract available

  31. NAKHATE V, Lasica AB, Aker L, Miller JJ, et al
    Prognostic Significance of Contrast Enhancement in Newly Diagnosed Grade 2 IDH-mutant Glioma.
    Neuro Oncol. 2026 Oct 16:noag262. doi: 10.1093.
    PubMed         Abstract available

  32. ROY R, Kerl K
    Hijacking Developmental Immunity: Inflammation and Immune Dysregulation in Pediatric Brain Tumors.
    Neuro Oncol. 2026 Oct 14:noag168. doi: 10.1093.
    PubMed         Abstract available

  33. KRONA C, Kundu S, Rosen E, Kruse F, et al
    A Multi-Omic Phenobank Reveals Axes of Glioblastoma Growth, Invasion, and Therapeutic Vulnerability.
    Neuro Oncol. 2026 Oct 12:noag255. doi: 10.1093.
    PubMed         Abstract available

  34. VENERE M
    Finding a new strategy to defeat an old foe: Overcoming radioresistance in glioblastoma.
    Neuro Oncol. 2026 Oct 16:noag263. doi: 10.1093.
    PubMed        

  35. MARCISCANO AE, Shih HA, Niyazi M
    Fine-tuning the beam: Biomarker-guided radiation strategies in the evolving management of isocitrate dehydrogenase (IDH)-mutant glioma.
    Neuro Oncol. 2026 Oct 10:noag169. doi: 10.1093.
    PubMed         Abstract available

  36. BECKER H, Walter B, Haeusser LA, Trampert J, et al
    Fanconi anemia pathway disruption drives lomustine sensitivity in glioma.
    Neuro Oncol. 2026 Oct 10:noag254. doi: 10.1093.
    PubMed         Abstract available

  37. BARBIER RH, Waitkus MS
    A Dual Role for SIRPalpha in Triple-Negative Breast Cancer Brain Metastasis.
    Neuro Oncol. 2026 Oct 10:noag243. doi: 10.1093.
    PubMed        

  38. KURZ SC, Preusser M
    Biomarker-guided and systemic treatment strategies for meningioma.
    Neuro Oncol. 2026 Oct 10:noag071. doi: 10.1093.
    PubMed         Abstract available


    Neurol Clin Pract

  39. LU-EMERSON C, Lee C, Still MEH, Ghiaseddin AP, et al
    Practical Review of Role and Usage of Corticosteroids in Modern Neuro-Oncology Care.
    Neurol Clin Pract. 2026;16:e200679.
    PubMed         Abstract available


    Neuroradiology

  40. AYGUN T, Keski?n A, Palanci O, Oztanir MN, et al
    Contralateral DTI-ALPS index as a prognostic biomarker in IDH-wildtype glioblastoma: integrating extent of resection and sex-stratified analyses.
    Neuroradiology. 2026 Oct 14. doi: 10.1007/s00234-026-04220.
    PubMed         Abstract available


    Neurosurgery

  41. BALES TR, Hernandez-Rovira MA, Pasupuleti CKA, Prabhu KN, et al
    Comparative Outcomes of Stereotactic Radiosurgery and Surgical Resection for Radiation-Induced Meningiomas.
    Neurosurgery. 2026 Oct 13. doi: 10.1227/neu.0000000000004242.
    PubMed         Abstract available


    Pediatr Neurol

  42. JAVED H, Adnan R, Ahmer W, Tariq S, et al
    Second-Course Reirradiation Versus No Reirradiation in Pediatric Diffuse Intrinsic Pontine Glioma: A Meta-Analysis of Survival Outcomes.
    Pediatr Neurol. 2026;185:98-105.
    PubMed         Abstract available


    PLoS One

  43. MOSTAFA RM, Mabrouk E, Salim MS, Ayman A, et al
    Brain tumor segmentation using a combination of graph cut and optimized U-Net with genetic algorithm: An efficient hybrid framework for enhanced medical image analysis.
    PLoS One. 2026;21:e0338773.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum